Position in ELAN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$246,469
-$37,436 QoQ
Shares Held
10,015
-15.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#355
of 519 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $9,277,599 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
91,535 | $6,577,705 | |
| 2 | HLN |
Haleon plc
|
101,287 | $945,007 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
5,265 | $887,363 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,803 | $399,885 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
10,015 | $246,469 | |
| 6 | VTRS |
Viatris Inc
|
12,346 | $196,054 | |
| 7 | TLPH |
Talphera, Inc.
|
15,133 | $15,586 | |
| 8 | CGC |
Canopy Growth Corp
|
10,032 | $9,530 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,469 | 10,015 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $283,905 | 11,864 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $276,063 | 12,199 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $261,658 | 12,992 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $163,406 | 11,443 | Shares | Defined | 2025-07-29 | |
| 2021-09-30 | $209,517 | 6,570 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $230,896 | 6,656 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||